Chemkart India

Chemkart India Limited - IPO

SME

Chemkart India IPO Details

Open Date
07 Jul 2025
Close Date
09 Jul 2025
Listing Date
14 Jul 2025
Issue Price
₹236 - ₹248
Face Value
₹10 per share
Lot Size
600
GMP
₹0
Issue Type
IPO
Listing On
BSE
Type
Book Built Issue
Share holding pre issue
9499000
Share holding post issue
12099000
Total Issue Size
32,29,200 shares (aggregating up to ₹80.08 Cr)
Fresh Issue
26,00,000 shares (aggregating up to ₹64.48 Cr)
Offer for Sale
6,29,200 shares (aggregating up to ₹15.60 Cr)

Chemkart India IPO Subscription

Chemkart India IPO Application Wise Breakup

Chemkart India IPO Dates

  • 07 Jul 2025
    Opening dateOPD
  • 09 Jul 2025
    Closing dateCOD
  • 10 Jul 2025
    Basis of AllotmentBOA
  • 11 Jul 2025
    Initiation of RefundsIOR
  • 11 Jul 2025
    Credit of SharesCOS
  • 14 Jul 2025
    Listing dateLID

Chemkart India IPO Lot Size

ApplicationLotsSharesAmount
Individual Minimum21200₹297,600
Individual Maximum21200₹297,600
SHNI Minimum31800₹446,400
SHNI Maximum63600₹892,800
BHNI Minimum74200₹1,041,600

Chemkart India IPO Reservation

Promoter Holding

Pre Issue:100.00%
Post Issue:73.31%
Promoter Names:
Mr. Ankit Shaileesh Mehta, Ms. Parul Shaileesh Mehta, Mr. Shaileesh Vinodrai Mehta

Chemkart India IPO Valuations

ROE:59%
ROCE:49%
DEBT/EQUITY:0.32
RONW:45.52%
PRICE TO BOOK VALUE:8.12
EPS Pre IPO:25.54
EPS Post IPO:20.05
P/E Pre IPO:9.71
P/E Post IPO:12.37

Chemkart India Limited Financial Information

Period Ended30 Sep 202431 Mar 202431 Mar 202331 Mar 2022
Assets85.4853.5137.4824.54
Revenue114.43132.83131.6987.43
Profit After Tax14.7414.527.665.48
Net Worth43.7629.0114.56.84
Reserves and Surplus42.427.6613.145.48
Total Borrowing21.3312.5511.335.66
Amount in ₹ Crore

About Chemkart India IPO

Incorporated in 2015, Chemkart India Limited is a distributor specializing in high-quality food and health ingredients. The company bridges the gap between global ingredient manufacturers and businesses across various sectors.

The company targets the B2B platform, providing products for manufacturing supplements like sports, health, vitamins, and protein. Focused on variety, affordability, quality, and customer relationships, it enhances supply chain processes.

The company provides grinding, blending, and packaging services at its hygienic facility in Bhiwandi, Mumbai. The 28,259.16 sq. ft. warehouse is equipped for efficient processing, labeling, and sealing of ingredients.

Products Portfolio:

  • Amino Acid: The Building blocks of proteins essential for biological processes and metabolism.
  • Health Supplement: Supplements with essential nutrients and bioactive compounds for wellbeing.
  • Herbal Extract: Extracts from plants used for therapeutic and functional benefits.
  • Nucleotide: Key components supporting immune health, gut health, and nutrition.
  • Protein: Vital for muscle growth, immune function, and overall health.
  • Sports Nutrition: Ingredients supporting athletic performance, endurance, and recovery.
  • Vitamins: Micronutrients essential for various bodily physiological functions.

As of January 31, 2025, the company had 31 employees.

 

Strength Of Chemkart India IPO

1. Diversified product portfolio.

2. In house processing and warehousing capabilities.

3. Value proposition for Customers.

Risk Of Chemkart India IPO

1. Our business operations rely significantly on the continuous and timely supply of products from top 5 and top 10 suppliers, Also, we do not have continuing and exclusive supply agreement with them. Any interruptions or discontinuation of same will adversely impact our overall performance and profitability.

2. We source our majority of the products from international market i.e. China. Any adverse developments affecting our procurement in this region could have an adverse impact on our revenue and results of operations.

3. We generate our majority of the sales from domestic market of which major portion of sales from our operations is generated from certain geographical regions especially, Maharashtra, Gujarat and New Delhi and minority portion of sales is from international market. Any adverse developments affecting our operations in these regions could have an adverse impact on our revenue and results of operations.

4. Our Registered Office is not owned by us. In the event we lose such rights, our Business, Financial Condition and Results of Operations and Cash Flows could be adversely affected.

5. The restated Consolidated financial statements have been provided by peer reviewed chartered accountants who is not statutory auditor of our Company.

6. We depend on certain customers for a significant portion of our revenues, Also, our Company in the usual course of Business does not have any long term contracts with its Customers and we rely on purchase orders for delivery of our products and our Customers may cancel or modify their orders, change quantities, delay or change their sourcing strategy. Loss of one or more of our top Customers or a reduction in their demand for our products or reduction in revenue derived from them may adversely affect our Business, Results of Operations and Financial Condition.

7. We have entered into and may enter into related party transactions in the future, however, there can be no assurance that such transactions, individually or taken together, will not have an adverse effect on our business, prospects, results of operations and financial condition.

8. There are certain discrepancies/errors/delay filings noticed in some of our corporate records relating to forms filed with the Registrar of Companies and other provisions of Companies Act, 2013. Any penalty or action taken by any regulatory authorities in future, for non-compliance with provisions of corporate or any other law could impact the financial position of the Company to that extent.

9. We have certain outstanding litigation against us, an adverse outcome of which may adversely affect our business, reputation and results of operations.

10. Our Company had not obtained Registration under FSSAI for its warehouse where its operations are carried on and have applied for modification in the FSSAI. We are not sure if the same shall be approved by the concerned authority or at all.

Objectives Chemkart India IPO

1. Financing the capital expenditure towards setting up of the Manufacturing Facility through investment in the Wholly-Owned Subsidiary (WOS) Company, Easy Raw Materials Private Limited

2. Repayment/prepayment of all or certain of the borrowings availed of by the Company

3. General Corporate Purpose

Company Contact Details

Chemkart India Limited
Office No. 403/404,
4th Floor, K.L. Accolade, 6th Road,
TPS III, Santacruz (East), Mumbai - 400055
Mumbai, Maharashtra
Phone: +91 9136383828
Email: investors@chemkart.com
Website: https://chemkart.com/

Registrar Contact Details

Name: Bigshare Services Pvt Ltd
Phone: +91-22-62638200

Lead Mangers

  1. Smart Horizon Capital Advisors Private Limited

Market Maker

  1. Alacrity Securities

Comments